The diagnostic value of a panel of monoclonal antibodies was assessed in 100 consecutive patients with acute leukaemia. Ninety-seven patients were clearly phenotyped. Clinical and haematological feedback showed that the immunological data made a critical contribution to the final haematological diagnosis in 19 patients and provided useful confirmatory data in another 78. Immunophenotype also provided the basis for a subset classification of known prognostic relevance to acute lymphoblastic leukaemia (ALL). Immunophenotype and haematological findings conflicted in 2 cases, and 3 cases were unclassifiable with the antibody panel. In these difficult cases leukaemic-cell DNA was investigated for immunoglobulin gene arrangement. Immunophenotypin...
BACKGROUND Leukaemias are biologically a diverse group of disorders with differences in their morph...
Acute leukaemia can be classified based on the findings of the morphology, cytochemistry studies, im...
Objectives Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic c...
Background and Objectives. The diagnosis of acute leukemias (AL) requires a multiparametric approach...
Diagnostic accuracy in acute leukemia (AL) can be improved if traditional morphology and cytochemist...
BACKGROUND AND OBJECTIVES: Flow cytometry is nowadays the preferred method for immunophenotypic id...
Thesis (Master Diploma(Medical Technology) -- Cape Technikon, Cape Town, 1990Eighty six patients wit...
The need for standardization criteria and result reproducibility in immunophenotyping hematological ...
Over a period of 3-1/2 years, 86 cases of acute leukemia were analyzed by immunohistochemical (IHC) ...
Laboratory diagnosis for acute leukemia classification is necessary for both treatment and prognosis...
Immunophenotyping of acute nonlymphocytic leukemia has confirmed previous observations on the hetero...
Immunophenotyping of acute nonlymphocytic leukemia has confirmed previous observations on the hetero...
The immunophenotype of 135 previously untreated patients with FAB defined acute myeloid leukaemia (A...
Until recently, the diagnosis and classification of acute myeloid (AML) and acute lymphoblastic (ALL...
The progressive availability of more sophisticated technologies has over the last few years allowed ...
BACKGROUND Leukaemias are biologically a diverse group of disorders with differences in their morph...
Acute leukaemia can be classified based on the findings of the morphology, cytochemistry studies, im...
Objectives Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic c...
Background and Objectives. The diagnosis of acute leukemias (AL) requires a multiparametric approach...
Diagnostic accuracy in acute leukemia (AL) can be improved if traditional morphology and cytochemist...
BACKGROUND AND OBJECTIVES: Flow cytometry is nowadays the preferred method for immunophenotypic id...
Thesis (Master Diploma(Medical Technology) -- Cape Technikon, Cape Town, 1990Eighty six patients wit...
The need for standardization criteria and result reproducibility in immunophenotyping hematological ...
Over a period of 3-1/2 years, 86 cases of acute leukemia were analyzed by immunohistochemical (IHC) ...
Laboratory diagnosis for acute leukemia classification is necessary for both treatment and prognosis...
Immunophenotyping of acute nonlymphocytic leukemia has confirmed previous observations on the hetero...
Immunophenotyping of acute nonlymphocytic leukemia has confirmed previous observations on the hetero...
The immunophenotype of 135 previously untreated patients with FAB defined acute myeloid leukaemia (A...
Until recently, the diagnosis and classification of acute myeloid (AML) and acute lymphoblastic (ALL...
The progressive availability of more sophisticated technologies has over the last few years allowed ...
BACKGROUND Leukaemias are biologically a diverse group of disorders with differences in their morph...
Acute leukaemia can be classified based on the findings of the morphology, cytochemistry studies, im...
Objectives Acute leukemia (AL) is a highly heterogeneous malignant disease caused by hematopoietic c...